Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors

The present invention relates to a novel heterocyclic compound of the formula (I) useful for inhibiting glycogen synthase kinase 3 (GSK-3) [Wherein the variable elements are as defined in the claims or the description of the specification. , Compositions containing the compounds, their use in the manufacture of a medicament for the treatment of medical disorders sensitive to treatment with compounds that modulate, preferably inhibit, the activity of glycogen synthase kinase 3β, and the compounds For the treatment of medical disorders sensitive to treatment with compounds that modulate glycogen synthase kinase 3β activity.